pelvic pain semaglutide Ozempic and GLP-1 Drugs: Risk of Severe Side Effects What Causes Lower Abdominal Pain

Other TRIUMPH Trials Additional Phase 3 trials in the TRIUMPH program are ongoing: TRIUMPH-1: Retatrutide in obesity (general population), results expected 2026 TRIUMPH-2: Retatrutide in type 2 diabetes, results expected 2026 TRIUMPH-3: Retatrutide cardiovascular outcomes trial, results expected 2027 Visualize Your Retatrutide Journey See how retatrutide builds up in your system over time and compare different dosing protocols

The incretin effect accounts for up to 60% of insulin secretion after oral glucose (83)

Ready to see BPC-157 & TB-500

Constipation and abdominal discomfort are also reported, though rates decline as the body adapts